EMA and HMA consult on common network strategy to 2020

A draft common strategy to 2020 for the European medicines agencies network has been opened for a three-month public consultation by the European Medicines Agency and the Heads of Medicines Agencies.

The consultation document outlines joint key priorities for the network and a high level strategy to achieve these. The need to work together to achieve goals is treated as an urgent priority, in particular the global threat faced by antimicrobial resistance and the need to be prepared for epidemics, such as Ebola. It also notes that the health care needs of patients in Europe are changing. More complex medicines are being developed, which may bring opportunities for personalized medicines and more treatments for rare diseases. Patients also require timely access to new, beneficial and safe medicines. The document also calls for greater collaboration with regulators beyond the European Union.

Sharing workloads